Author:
Li Yiran,Jin Xiaofei,Wang Feilong,Zhou Huijing,Gu Yueqing,Yang Yamin,Qian Zhiyu,Li Weitao
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology
Reference32 articles.
1. Rowland M (2020) Physiologically-based pharmacokinetic (PBPK) modeling and simulations principles, methods, and applications in the pharmaceutical industry. CPT-Pharmacomet Syst 2(7):e55
2. Sager JE, Yu J, Ragueneau-Majlessi I, Isoherranen N (2015) Physiologically based pharmacokinetic (PBPK) modeling and simulation approaches: a systematic review of published models, applications, and model verification. Drug Metab Dispos 43(11):1823–1837
3. Zhang Y, Zhang L, Yin G et al (2019) In vivo pharmacokinetics assessment of indocyanine green-loaded nanoparticles in tumor tissue with a dynamic diffuse fluorescence tomography system. Mol Imaging Biol 21:1044–1053
4. Yao L, Ren L, Chen Q et al (2022) Rapid and direct concentration range judgment of lamotrigine in plasma by the multi test lines with different detection limits on the same lateral flow strip. Anal Chim Acta 1192:339347
5. Jiang W, Yang JJ, Cao L, Xiao X, Shi XL, Cao YX (2016) Modifications of the method for calculating absolute drug bioavailability. J Pharm Pharm Sci 19(2):181–187